Rocket Lab Rallies Past $118 as Record $2.2B Backlog and Space Systems Dominance Offset Sector Shocks
05.06.2026 - 06:06:33 | boerse-global.de
Rocket Lab’s shares are clawing back ground after a turbulent stretch that knocked the stock 16% lower in a single week. By Thursday, the equity had recovered to $118.25, adding about 3% as investors sifted through a mix of sector shocks and company-specific milestones.
The recent sell-off had multiple triggers. A test flight explosion at Blue Origin in late May spooked the entire space sector, while insider selling — with executives and near-insiders cashing out roughly $18.4 million worth of stock — added to the pressure. Analysts also point to capital rotation ahead of SpaceX’s highly anticipated IPO on June 12, with profit-taking hitting names like Rocket Lab after a 350%-plus run over the past twelve months.
Yet beneath the headline volatility, the company’s fundamentals are telling a different story. Rocket Lab’s first-quarter 2026 revenue hit $200.3 million, a 63.5% surge year-over-year that comfortably beat consensus estimates of just under $190 million. Even more striking is the structural shift in revenue composition: Space Systems — encompassing satellite manufacturing and component deliveries — now accounts for 68% of total sales, replacing the lumpy revenue profile of launch services with a far more predictable base.
The order book has never been thicker. Rocket Lab ended Q1 2026 with a record backlog of $2.2 billion, anchored by several multi-year defense programs. The Space Development Agency’s satellite constellation project alone, valued at roughly $816 million, passed a critical System Requirement Review in recent weeks, confirming the Lightning satellite platform meets U.S. defense architecture standards. A $90 million contract from the U.S. Space Force and the ongoing Hypersonic Accelerator Suborbital Test Electron (HASTE) program for hypersonic test flights further shore up the pipeline.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
The company now expects second-quarter revenue in a range of $225 million to $240 million, signaling continued momentum. Stifel analyst Erik Rasmussen lifted his price target to $132, the Street-high among analysts covering the name, citing strong topline growth and the upcoming maiden flight of the Neutron rocket in the fourth quarter.
Two key events on the June calendar are now in the spotlight. On June 10, Rocket Lab will launch the “Curveball” mission under the HASTE hypersonic program. It is part of an aggressive launch cadence that targets 15 to 20 missions for the full year 2026. Two days later, the SpaceX IPO will test the market’s appetite for pure-play space names, with potential spillover effects on valuation sentiment for competitors like Rocket Lab.
Technically, the stock sits in neutral territory: the Relative Strength Index (RSI) stands at 51.0, neither overbought nor oversold. The price remains roughly 24% above its 50-day moving average, indicating medium-term stability despite the recent drawdown. Rocket Lab closed near $120, about 21% below its 52-week high of $151 set on May 27, though year-to-date gains still stand at nearly 58%.
Rocket Lab USA at a turning point? This analysis reveals what investors need to know now.
On the operational front, the Neutron rocket’s first flight in Q4 2026 and the planned acquisition of Motiv Space Systems to expand robotic space capabilities provide the next catalysts. With a $2.2 billion backlog as a buffer and Space Systems delivering recurring revenue, Rocket Lab’s near-term narrative hinges less on sudden stock movements and more on execution against a packed launch manifest and defense contract milestones.
Ad
Rocket Lab USA Stock: New Analysis - 5 June
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
